CROI 2024 Report Back: Treatment Updates
HTML-код
- Опубликовано: 14 апр 2024
- Dr. Jehan Budak summarizes key study results from the CROI 2024 conference that focus on antiretroviral treatment, especially long-acting injectable cabotegravir/rilpivirine and lenacapavir.